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Recent studies have found that certain urinary proteins can efficiently inhibit stone formation. These
discoveries are significant for developing effective therapies for stone disease, but the inhibitionmechanism
of crystallization remains elusive. In the present study, polyaspartic acid (PASP) was employed as a model
peptide to investigate the effect of urinary proteins on the crystallization and morphological evolution of
struvite. The results demonstrate that selective adsorption/binding of PASP onto the {010} and {101} faces of
struvite crystals results in arrowhead-shapedmorphology, which further evolves into X-shaped and unusual
tabular structures with time. Noticeably, these morphologies are reminiscent of biogenic struvite
morphology. Concentration-dependent experiments show that PASP can inhibit struvite growth and the
inhibitory capacity increases with increasing PASP concentration, whereas aspartic acid monomers do not
show a significant effect. Considering that PASP is a structural and functional analogue of the subdomains
of aspartic acid-rich proteins, our results reveal that aspartic acid-rich proteins play a key role in regulating
biogenic struvite morphology, and aspartic acid residues contribute to the inhibitory capacity of urinary
proteins. The potential implications of PASP for developing therapeutic agents for urinary stone disease is
also discussed.
B
iologically controlled mineralization has been observed in many living organisms in nature. This creates
various functional biominerals, such as mollusk shells, bones, teeth, and magnetosomes in magnetotactic
bacteria1–7. Numerous investigations have revealed that some special acidic proteins play a major role in
precisely controlling the formation of biominerals with unique morphologies1,5,8,9. On the contrary, pathological
biomineralizations which include various diseases, such as urinary stones, gallstones, and atherosclerosis10–14, lack
biological control. To conquer these diseases, researchers have made great efforts to reveal the mechanisms of
stone formation, and have found that many natural modulators have a stimulatory or inhibitory influence on the
crystallization and retention of stones in body fluids15–22. The most potent modulators are proteins enriched in
acidic amino acid residues, such as aspartic or glutamic acids16,18,21–24.
Among the pathological stones, urinary stones, which have been plaguing human beings since the beginning of
civilization25 are vitally important, causing symptoms in 3–20% of people throughout the world with a recurrence
rate of 50%26. The main constituents of urinary stones are calcium oxalate, calcium phosphate, struvite, uric acid,
and cysteine10. Struvite, known as magnesium ammonium phosphate hexahydrate (NH4MgPO4?6H2O), crystal-
lizes in the orthorhombic system and accounts for 15 to 20% of all urinary stones10. The formation of struvite is
associated with a urinary tract infection by urease-producing microorganisms, including Proteus mirabilis10,11,27,
which occurs because urease can split urea into carbon dioxide and ammonia. Generated ammonia increases the
urinary pH, which leads to an elevation of the concentration ofNH41, CO322, and PO432. These ions subsequently
combine with Mg21 cations present in urine to precipitate struvite.
Struvite formation is among the most difficult and dangerous conditions in stone disease as it can rapidly grow
in human body with a high degree of recurrence and presents the damaging appearance of a ‘‘staghorn’’11,28–32. In
vitro experiments also found similar dendrites when struvite was formed in synthetic urine in the presence of
Proteus mirabilis26,33. Such staghorns and dendrites can easily remain to form larger stones and at the same time
damage the epithelium of the internal renal walls26. The affected areas can in turn serve as nucleation sites for
struvite crystallization, promoting the crystal growth and aggregation of struvite26. Therefore, it is the crystal
morphology that creates a vicious circle for stone formation andmakes struvite amore painful urological disorder
OPEN
SUBJECT AREAS:
PATHOGENESIS
MINERALOGY
Received
24 June 2014
Accepted
9 December 2014
Published
16 January 2015
Correspondence and
requests for materials
should be addressed to
G.-T.Z. (gtzhou@ustc.
edu.cn)
SCIENTIFIC REPORTS | 5 : 7718 | DOI: 10.1038/srep07718 1
in human body. In addition to the staghorn-like and dendritic
morphologies, biogenic struvite also presents other special features,
such as X-shaped and unusual tabular habits (with an ‘X’ on the
surface), which are significantly different from their abiotic
counterparts27,33–38.
In view of these special morphologies and their disadvantages,
struvite morphogenesis has been increasingly recently investigated
using two principal methodologies. The first approach explores the
metabolic effects on the morphology of struvite crystals in the media
of urease-producing microorganisms isolated from infectious
stones26,27,33,35,37–39. The second approach is based on biomimetic
model systems, and examines the influence of biological macromo-
lecules and synthetic polymers on crystal morphogenesis29,36,40,41. In
the first approach, it is presumed that these special morphologies
depend on either supersaturation or growth kinetics. For example,
Mclean et al. noted that the crystal habit of struvite varies markedly
according to the growth rate35. That is, high growth rates lead to
elongation along one or two crystal planes, inducing the appearance
of dendritic or X-shaped crystals. When the growth rate slows down,
tabular crystals develop. Prywer and Torzewska also observed X-
shaped and dendritic morphologies during the mineralization of
struvite crystals with Proteus bacteria in synthetic urine27. They sug-
gested that these morphologies are caused by heterogeneous distri-
bution of supersaturation around the growing crystals, which is
highest at the corners and edges and lowest at the center of a given
crystal surface. Recently, Prywer et al. reported that high supersa-
turation might change the tendency of primary crystals to form
rhombohedra, which are well aligned and arranged layer-on-layer
to form the X-shaped structures33. Using the second approach, inves-
tigators have found that some proteins, such as calprotectin, albumin
and immunoglobulins, might inhibit the growth of struvite36,40.
Moreover, Asakura et al. observed X-shaped morphology when they
tested the effect of calprotectin on urease-induced struvite growth in
artificial urine36. These findings raised further questions, e.g.,
whether there is a close relationship between urinary proteins and
biogenic struvite morphologies, and why some urinary proteins can
inhibit struvite growth.
Herein, polyaspartic acid (PASP) was chosen as amodel biological
additive to influence the crystallization and growth of struvite, and an
ammonia diffusion technique was used to synthesize struvite, which
might emulate the biomineralization of struvite in vivo. The goal of
this study was to examine the effect of PASP on the growth and
morphological development of struvite and to reveal the morphoge-
netic mechanism of biogenic struvite. Our results showed that in the
presence of PASP, struvite with biogenic structures can be crystal-
lized, and a series of time-resolved experiments revealed that struvite
crystals experienced a significant morphologic evolution from
arrowhead-shaped throughX-shaped to unusual tabular habits (with
an ‘X’ on the surface). A plausible mechanism for the morphogenesis
of hierarchical struvite crystals was proposed. Remarkable reduc-
tions in struvite dimensions and total mass were also observed with
a continuous increase in PASP concentration, which may explain
why a number of urinary proteins acted as stone growth inhibitors
in urine, leading to a better understanding of pathological biominer-
alization and the application of PASP to lithiasis treatment.
Results
In order to understand the effect of PASP on the morphological
evolution of struvite, a series of time-resolved mineralization experi-
ments from 20 min to 20 h was carried out at PASP concentrations
of 0 and 0.2 mM, respectively. The composition and phase purity of
the products were first examined by the XRD technique, and the
results confirm that all of themineralized products are orthorhombic
struvite with space group Pmn21. The representative XRD patterns
for the products obtained with and without PASP are shown in
Figure 1a–c. Compared with the standard diffraction pattern of stru-
vite (in Figure 1, JCPDS file No.15–0762), all of the diffraction peaks
could be well indexed as struvite, and no other impurity phases could
be found. At the same time, it is not difficult to find from Figure 1a–c
that the products obtained in the presence of PASP had dramatically
strong (020) and (040) diffractions, indicating that the mineralized
products were preferentially oriented along the [010] direction.
Moreover, FT-IR analysis has also been proved to be a valuable
method to distinguish the different phases and compositions42.
Therefore, FT-IR analyses were performed on the mineralized pro-
ducts. The typical FT-IR spectra of the mineralized products with
and without PASP are depicted in Figure 2. The absorption bands
located at 1007, 572 and 462 cm21 can be assigned to the PO432
antisymmetric stretch (n3), the P-O bend (n4) and the PO432 n2
modes, respectively. The absorption bands at 1469, 1435 and
1400 cm21 can be attributed to n4 (NH41) antisymmetric bending.
Water-water H bonding at 761 cm21 and ammonium-water H
bonding at 892 cm21 can also be recognized from this FTIR spec-
trum. These are in good agreement with the results for pure struvite
reported by Banks et al.42, further confirming that the mineralized
products are struvite. Therefore, the XRD and FT-IR results reveal
that pure phase of struvite can always be obtained in the presence and
absence of PASP, and dissolved PASP in the mineralization solution
does not influence the phase composition of the mineralized pro-
ducts.Moreover, the characteristic vibrational bands [band of n (C5
O) in amide group at approximately 1645 cm21, band of n (C5O) in
carboxylic group near 1731 cm21, band of n (C-H) in methylene
group at approximately 2969 and 2904 cm21] belonging to PASP
molecules43 do not appear in Figure 2a, suggesting that no detectable
content of PASP is occluded in the mineralized product after extens-
ive washing.
The morphology and textures of the mineralized products were
further observed by FESEM. In the presence of 0.2 mM PASP, a
range of struvite crystals with different morphologies was obtained
at different mineralization durations, as shown in Figure 3, panels
a1–f1. At 20 min, very little sample is obtained, mainly containing
crystals with an arrowhead-shaped morphology with a mean dimen-
sion of ca. 10 mm (Figure 3, panel a1). It appears that the arrowhead-
like crystals exhibit typical hemimorphic morphology, that is, the
two ends of a crystallographic c-axis are not related by symmetry27.
It is well known that struvite has an orthorhombic structure with
space group Pmn21. Therefore, the arrowhead-like crystal can be
described as a crystallographic combination consisting of the {001}
Figure 1 | Representative XRD patterns of the samples grown for 2 h
with 0.2 mMPASP (a), 8 hwith 0.2 mMPASP (b), 8 hwithout PASP (c),
2 h with aspartic acid (d), and the standard XRD pattern for struvite
(JCPDS file No. 15–0762).
www.nature.com/scientificreports
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and {00-1} pedions, the {101}, {01-1}, {10-1} and {011} domes, and
the {010} pinacoid, as illustrated in Figure 3, panel a1. After 1 h of
mineralization, a few more crystals are generated and the morpho-
logy exhibits a quadrangular tabular habit with a length of ca. 30 mm
and a width of ca. 20 mm (Figure 3, panel b1). Nevertheless, the
striations and voids left on the quadrangular tabular structures indi-
cate that the tabular architectures are assembled from four arrow-
head-shaped crystals. The quadrangular tabular architecture is
almost 4 times as large as the arrowhead-shaped structure, further
supporting that an assembly process might occur. Furthermore, FIB/
SEM analyses show that the middle of cross section in the architec-
ture has a much rougher and porous appearance (see Supplementary
Fig. S1d online), which reveals that the fusion and topotactic growth
are incomplete in the boundary of subunits, confirming that the
quadrangular tabular structures form from a self-assembly of the
arrowhead-like subunits. The quadrangular tabular structures were
further characterized by the TEM and SAED techniques.
Unfortunately, no TEM image and SAED pattern for the architec-
tures is available due to the quick melting and decomposition of
struvite under the bombardment of the electron beam. In fact, our
TG–DTA analyses also indicate that struvite easily loses its six water
molecules and an ammonia molecule at lower temperatures (see
Supplementary Fig. S2 online). At a mineralization time of 2 h, the
X-shaped structures are observed, as shown in Figure 3, panel c1. The
four extended angles in the X-shaped structures reveal that the pref-
erential growth occurs along the ,001. direction of every
assembled subunit. This characteristic X shape has been reported
by several researchers when struvite crystallized in the presence of
urease-producing bacteria26,27,33,35,37,38. After 3 h of mineralization,
the X-shaped crystal develops a more tabular appearance with the
void spaces gradually filled by the peripheral growth, leaving an ‘X’
on the top surface (Figure 3, panel d1). Prolonging mineralization
time to 8 h leads to the appearance of unusual tabula-like structures
with a length of ca. 80 mmand a width of ca. 30 mm, and almost all of
the tabulae are truncated (Figure 3, panel e1). Additionally, it can
clearly be seen that there is an ‘X’ on the top surface while the
opposite side is flat. This unusual tabular habit is similar to the
biogenic struvite morphology reported by Mclean et al., Prywer
and Torzewska, and Zhu et al.35,37,38. At a mineralization time of
20 h, regrowth and/or Ostwald ripening blur the ‘X’ on the surface
of the unusual tabular struvite, resulting in a flatter tabular morpho-
logy, with a length of ca. 100 mm and a width of ca. 30 mm (Figure 3,
panel f1). However, in the absence of PASP, only the rod-shaped or
long tabular crystals are harvested with a length of hundreds of
micrometers, as depicted in Figure 3, panels a2–f2. Specifically,
panels a2 and b2 in Figure 3 show that the products mineralized
for 20 minutes and 1 h consist mainly of rod-shaped crystals. At a
mineralization duration of 2 h, some rod-like crystals develop into
penniform-like structures with saw-toothed sides (Figure 3, panel
c2). After 8 h of mineralization, the long tabular habits dominate
the crystal’s appearance (Figure 3, panel e2). A further extension of
the mineralization time to 20 h leads to the huge tabular habit
(Figure 3, panel f2). Concisely, a series of time-course experiments
with and without PASP revealed that PASP plays an important role
in the specific morphogenesis of struvite.
Moreover, in order to better understand the effect of PASP on
struvite crystal growth, mineralization experiments with different
concentrations of PASP were also carried out, and a 2 h mineraliza-
tion time was deliberately chosen because our time-resolved experi-
ments indicated that the orientation aggregation/assembly of the
struvite subunits occurs between 1 and 2 h (Figure 3, panels b1
and c1). In the absence of PASP, a large number of long penniform
crystals was obtained, with a length of ca. 190 mm (e.g., Figure 3,
panel c2). However, when 0.1 mM of PASP was added, the product
had a large X-shape with a length of ca. 100 mm, and some attached
grains forming two intersecting lines on the surface could also be
seen (Figure 4a). If the PASP concentration was increased to 0.2 mM,
the X-shapes still dominated the crystallization habits, but the
lengths were reduced to 50 mm (e.g., Figure 3, panel c1). At a
PASP concentration of 0.4 mM, both X-shaped and short tabular
habits coexisted, with a length of ca. 30 mm and ca. 20 mm, respect-
ively (Figure 4b).When the PASP concentration reached 0.8 mM, all
of the crystals had a short tabular habit and the mean length was
20 mm (Figure 4c). However, further increasing PASP concentration
to 2 mM did not lead to a remarkable change in the shape and size of
struvite (Figure 4d), only a reduced output. In order to unambigu-
ously demonstrate the dependence of the yield and dimensions of the
mineralized struvite on PASP, all trials were conducted five times to
calculate a mean yield, and 30 particles from the SEM images were
measured in each case to determine an average length. As shown in
Figure 5, either the yield or dimensions of struvite dramatically
decreases with an increase in the PASP concentration. Although
the inhibitory effect on the dimension was tested at saturation after
the addition of 0.8 mMof PASP, the yield of struvite consistently and
dramatically decreases. It appears that PASP not only significantly
impacts the morphology of struvite but also effectively inhibits the
nucleation and growth of struvite.
Discussion
PASP has been widely used as a model peptide to understand the
interaction between biomineralization-associated acidic proteins
and minerals such as calcium carbonate, calcium oxalate, calcium
hydrogenphosphate dehydrate, and octacalcium phosphate18,44–48.
Moreover, PASP has also been documented as an excellent inhibitor
to effectively inhibit crystal growth of calcium carbonate, calcium
sulfate, calcium oxalate, calcium phosphate, and barium sulfate
salts46,48–54. It is generally believed that its inhibitory effect could be
achieved in two ways. On the one hand, PASP could selectively bind
to some specific crystal faces by its carboxyl chains and hence
decrease their growth rates44,46,48,52. On the other hand, PASP could
serve as an excellent chelating agent, thus forming stable complexes
with variousmetal cations in solution55–57, in which the activity of the
free metal cations would be significantly reduced to restrain the
growth of crystal.
Our time-resolved experiments show that in the presence of PASP,
struvite exhibited different morphologies over time, including
arrowhead-shaped, X-shaped and unusual tabular morphologies
(Figure 3), and the arrowhead-like structures might act as the prim-
ary assembled subunits of the X-shaped and unusual tabular struc-
tures. However, in the absence of PASP, 20 min of mineralization
Figure 2 | FTIR spectra of the products grown for 8 h with 0.2 mM (a)
and 0 mM (b) PASP.
www.nature.com/scientificreports
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only leads to rod-like or long tabular crystals, while no arrowhead-
like struvite can be found (Figure 3, panel a2). This indicates that the
PASPmolecules are likely responsible for the formation of the special
arrowhead-like subunits. Wierzbicki et al. also obtained arrowhead-
shaped crystals when they examined the inhibitory effect of phos-
phocitrate on struvite crystal growth58. They suggested that phos-
phocitrates preferentially binding to {101} faces lead to an enhanced
expression of these faces, thus modifying the crystal morphology. In
our case, the arrowhead-shaped crystals have preferably developed
{101}, {010} and {01-1} faces (e.g., Figure 3, panel a1). This indicates
that the preferential adsorption and binding of PASP onto these faces
occurs and results in the prominent development of these faces.
Molecular simulations by Wierzbicki et al. and Romanowski et al.
have shown that the {101} and {010} faces of struvite have high
density of magnesium cations coordinated with water molecules31,58.
Our molecular modeling results also showed that the well-developed
{101} and {010} faces have a much higher density of Mg21 than the
less developed {011} faces (see Supplementary Fig. S3 and S4 online).
These crystal faces with a highMg content could provide a positively
charged environment for the preferential adsorption and binding of
negatively charged species. PASP molecules contain a large number
of negatively charged carboxyl side chains. Therefore, strong electro-
Figure 3 | FESEM images of struvite crystals synthesized for 20 min (a1, a2), 1 h (b1, b2), 2 h (c1, c2), 3 h (d1, d2), 8 h (e1, e2) and 20 h (f1, f2) with
0.2 mM PASP and without PASP, respectively.
www.nature.com/scientificreports
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static interactions occur between PASP molecules and the {101} and
{010} faces. The decrease of growth rate in turn leads to an enhanced
expression of the {101} and {010} faces. Other faces with a low density
of magnesium cations or the presence of negatively charged phos-
phate groups will cause a lack of attraction for PASP, and grow faster.
For example, the (011) face with lower density of Mg21 shows
reduced expression in the arrowhead-shaped morphology (e.g.,
Supplementary Fig. S4 and Figure 3, panel a1). Moreover, the XRD
analyses (Figure 1a and b) also show that the products obtained in the
presence of 0.2 mM PASP after 2 and 8 h of mineralization have
much stronger (020) and (040) diffractions relative to the standard
pattern of struvite (JCPDS file No.15-0762), further confirming the
existence of the well-developed {010} faces.
After arrowhead-shaped struvite forms, every four arrowhead-
shaped crystals further self-assemble into quadrangular tabular
architecture (Figure 3, panel b1). Here, the driving force controlling
the self-assembly process may result from long-range dipole-dipole
interactions between the assembled units33,59,60. As described by
Prywer et al., the (001) face in struvite is rich in NH41 groups, while
(00-1) face is rich in PO432 andMg(H2O)621 groups33. As a result, the
c axis is the dipole axis. Therefore, the intrinsic dipole-dipole inter-
actions from the arrowhead-shaped crystals should drive them to
orient and attach along coherent crystallographic directions, forming
quadrangular tabular architectures (e.g., Figure 3, panel b1).With the
further prolongation of the mineralization duration, the assembled
tabular architectures continue growing along the ,001. direction
with a relatively high growth rate, resulting in the X-shaped mor-
phology (Figure 3, panel c1). Subsequently, the peripheral growth
gradually fills the voids in the X-shaped structures, and the X-shaped
morphology evolves into unusual tabular habits with an ‘X’ on the
top surface (Figure 3, panel e1). Finally, the Ostwald ripening process
smoothens the surface and the conspicuous ‘X’ disappears (Figure 3,
panel f1).
Taken together, our time-resolved experiments indicate that in the
presence of PASP, a significant morphological evolution of struvite
occurs from the arrowhead-like shape through the assembled
Figure 4 | FESEM images of struvite crystals grown for 2 h with 0.1 mM (a), 0.4 mM (b), 0.8 mM (c) and 2 mM (d) PASP.
Figure 5 | Relationship between PASP concentrations and weight (a) or length (b) of struvite obtained in the concentration-dependent experiments.
www.nature.com/scientificreports
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quadrangular tabular architecture, the X-shape, and the unusual
tabula to the flatter tabular structure with a blurred X on its surface.
Such process can be clearly illustrated in Figure 6, and be achieved by
a train of steps, including the selective adsorption/anchoring of PASP
molecules, oriented attachment and fusion of the subunit, orienta-
tion growth, peripheral growth, and Ostwald ripening. Among these
obtained shapes, the X-shaped and unusual tabular habits resemble
biogenic morphologies of struvite. This suggests that biogenic X-
shaped and unusual tabular struvite may represent two different
growth stages, and that the aspartic acid-rich urinary proteins can
be responsible for the specific morphogenesis of biogenic struvite. In
the other words, biogenic struvite morphology can be developed
under the control of urinary proteins, and the biogenic X-shaped
and unusual tabular habits are the metastable growth forms of the
biogenic struvite. Therefore, our results can provide a new insight
into the biological origin of struvite with a variety of morphologies.
PASP concentration is another important factor for the crystal
growth of struvite. Without PASP, struvite grows rapidly and a mass
of penniform crystals with a length of ca. 190 mm are obtained
(Figures 3 and 5). However, when 0.1 mM of PASP is added, struvite
shows a regular X-shape and the crystal size is nearly halved. Further
increasing the PASP concentration results in a decrease of crystal size
and yield (Figures 4 and 5). These results indicate that PASP can also
effectively inhibit struvite growth in solution. It has been reported
that metal cations complex with PASP to form metal2PASP species
because PASP contains a mass of carboxyl groups55,57. Therefore,
PASP molecules can tightly combine with Mg21 to form magnes-
ium-PASP complexes, resulting in the effective growth inhibition of
struvite.
Moreover, our experiments using aspartic acid instead of PASP
show that in the presence of aspartic acid, plenty of long irregular
tabular struvite crystals (Figure 7) can be obtained (the XRD shown
in Figure 1d). This shows that the aspartic acid monomer cannot
exert a similar influence on the specific morphogenesis and growth
inhibition of struvite as PASP in spite of the same stoichiometry of
their respective carboxyl groups. Similar results have also been
observed in the interactions between aspartic acid and other miner-
als, such as calcium hydrogenphosphate dihydrate and calcium oxal-
ate monohydrate46,51, indicating that a mass of carboxyl groups is
insufficient to inhibit crystal growth and regulate the morphogenesis
of struvite. It appears that the remarkable various effects can be
attributed to the different molecule structures between PASP and
aspartic acid. Using the circular dichroism technique, Addadi et al.
confirmed that PASP with a molecular weight 6000 adopts a con-
formation comprising approximately 40% b-sheet and 60% random
coil in Ca21 solution61. The b-sheet conformation may favor the
formation of more coordination bonds between PASP side chain
carboxyl groups and magnesium cations exposed on the crystal face
of struvite, and facilitate a structural and stereochemical fit between
the distances of carboxylic groups in the PASP and the distances of
neighboring magnesium cations from struvite crystal faces46,48. In
this way, PASP binds tightly with the crystal faces and regulates
struvite morphogenesis. However, recent studies also demonstrated
that many mineral-associated proteins lack periodic structures even
when adsorbed to crystals62–64, and thus Hunter et al. proposed a
flexible polyelectrolyte hypothesis of protein-biomineral inter-
action64. In this model, protein-crystal interactions essentially
involve a general electrostatic attraction rather than structural com-
plementarities between the protein conformation and the crystal
face. Therefore, the different mineralization effects between PASP
and aspartic acid can also be reasonably interpreted as a high negative
density and conformation flexibility of PASP relative to aspartic acid.
At the same time, a mass of carboxyl groups allows for effective
complexation between PASP and Mg21 in solution, resulting in the
growth inhibition of struvite. Therefore, comparative experiments
with PASP and aspartic acid may highlight the importance of mole-
cule conformation in morphogenesis and the growth inhibition of
struvite. Based on these findings, it can safely be concluded that both
the component (e.g., carboxylic functional group) and structure
(chain length andmolecule conformation) lead to the high inhibitory
effectiveness of PASP. Furthermore, it should be kept in mind that
PASP is a structural and functional analogue of aspartic acid residues
in acidic proteins while aspartic acid residues are important compo-
nents of some key urinary proteins intimately involved in the patho-
logical mineralization processes of urinary stones18. For example,
osteopontin contains approximately 15–20% aspartic acid residues24
and nephrocalcin contains approximately 11%51. Hence, we propose
that aspartic acid residues or peptide chains in urinary proteins make
an important contribution not only to the morphogenesis but also to
the growth inhibition of the struvite stones.
Implication for pathological biomineralization
Struvite stones formed in human body tend to be staghorn-like
structures while similar dendrites appear in bacterially induced
mineralization experiments11,26,28,33. These branched struvite stones
cause harm to the human body by blocking the urinary tract and
damaging the urinary tract and kidneys26. Therefore, understanding
the formation mechanism of these morphologies is important for
treating urinary calculus. Although some investigations have pro-
posed that the special morphologies depend on either supersatura-
tion or growth kinetics, very few have implicated urinary
proteins26,27,33,35. Recently, urinary proteomics has led to the iden-
Figure 6 | Schematic illustration of the morphology evolution process of
struvite in the presence of PASP.
Figure 7 | FESEM image of the sample grown for 2 h in the presence of
aspartic acid.
www.nature.com/scientificreports
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tification of thousands of proteins in urine where urinary stones
form65, and an increasing number of papers have revealed that urin-
ary proteins play a key role in controlling the crystal growth of
urinary stones15,17,18,21,22. In our case, PASP was chosen as a model
peptide to investigate the impact of urinary proteins on struvite
morphogenesis. Our time-resolved experiments indicate that PASP
at a relatively low concentration can induce a series of specific
morphologies of struvite. Interestingly, the obtained X-shaped crys-
tals and crystals with unusual tabular habits are reminiscent of bio-
genic struvite morphologies26,27,33,35,37,38. We also find that these
uniquemorphologies are not isolated from each other but temporally
connected. Therefore this reveals the morphogenesis mechanism of
biogenic struvite and emphasizes the importance of aspartic acid-
rich urinary proteins on the morphological control of struvite.
Moreover, in view of the complex components in urine, X-shaped
struvite most likely develops into staghorn-like and dendritic stones
after aggregation and assembly. For example, Prywer and Torzewska
observed that X-shaped struvite crystals turn into dendrites in bac-
terial mineralization experiments27. In other words, staghorn calculi
frequently occurring in the human body can be induced by aspartic
acid-rich urinary proteins at a relatively low concentration.
Concentration-dependent experiments show that PASP at a rela-
tively high concentration can effectively inhibit struvite growth while
aspartic acid monomers show no significant effect. Hence, urinary
proteins may also exert an inhibitory capacity on struvite growth by
means of their aspartic acid residues, in accordance with the finding
that a number of inhibitory proteins are enriched with aspartic acid
residues16,18,21–24.
Taken together, our experiments indicate that aspartic acid resi-
dues in urinary proteins may exert either a positive or negative effect
on struvite growth. That is, high concentration aspartic acid-rich
proteins can effectively inhibit struvite growth. When the protein
concentration is reduced by pathological changes or the incorpora-
tion in crystals of the growing stone, the inhibitory capacity will
decrease accordingly18. What is worse, a relatively low protein con-
centration will induce the formation of staghorn-like and dendritic
struvite stones. Similarly, the dual functional roles of proteins have
been found in other cases18,21,66. For example, dentin phosphophoryn
can act as an inhibitor of hydroxyapatite nucleation and growth in
solution or can nucleate the formation of hydroxyapatite when
adsorbed on a solid surface21.
Indeed, concentration-dependent experiments have confirmed
that PASP can effectively inhibit struvite growth. Previous studies
have also reported that PASP had a similar inhibitory capacity on the
crystal growth of calcium oxalate and calcium phosphate46,50–53.
These three minerals make up the key components of urinary
stones10. That is to say, PASP is a good inhibitor of urinary stone
formation. Moreover, PASP can promote the dissolution of calcium
oxalate and calcium phosphate due to its ability to chelate metal ions
in solution51,67. We also found that PASP could be a driving force for
struvite dissolution (data not shown). Therefore, PASP could accel-
erate the dissolution of urinary stones already existing in the human
body. Moreover, PASP has excellent properties, including its
water-solubility, nontoxic nature, biodegradability, and biocompa-
tibility54,68–70. Therefore, PASP can potentially be developed into a
therapeutic drug for urinary stone disease. As such, this study pro-
vides a new insight into the pathological biomineralization and a
path toward the eventual design of therapeutic agents for urinary
stone disease.
Methods
All starting chemicals were obtained commercially without further purification.
Ammonia water (NH3?H2O), ammonium dihydrogen phosphate (NH4H2PO4),
magnesium chloride hexahydrate (MgCl2?6H2O), sodium hydroxide (NaOH), poly-
L-aspartic acid [(C4H5NO3) N] and L-aspartic acid (C4H7NO4) were of analytical
grade. In particular, PASP was purchased from Chengdu Ai Keda Chemical
Technology Co., Ltd and themolecular weight was 5000. Deionized water was used in
all our experiments.
The biomimetic growth of struvite was conducted in an ammonia diffusion system
at room temperature. In a typical biomimetic synthesis, 0.05 g (0.01 mmol) of PASP
and 0.0407 g (0.2 mmol) of MgCl2?6H2O were dissolved in a 50-mL beaker con-
taining 50 mL deionized water with mild stirring, followed by the addition of 0.023 g
(0.2 mmol) of NH4H2PO4. After continuous stirring a homogeneous solution was
obtained and the pH of the solution was adjusted to 7.0 using a diluted NaOH
solution. The beaker was covered with stretched parafilm into which six needle holes
were punched, and placed into a closed desiccator. A bottle (30 mL) of diluted
ammonia water (5 mol/L) was also placed in the desiccator as a source of ammonia.
After 8 h of mineralization, the product was isolated by centrifugation (1400 g for
3 minutes), cleaned by three cycles of centrifugation/washing/redispersion in deio-
nized water and ethanol, to remove the organic components possibly adsorbed on the
mineral surfaces, and allowed to dry at room temperature for 1 day. The same
procedures were employed in a series of time-resolved experiments and PASP con-
centration-dependent experiments. Comparative experiments were also performed
with the same procedure without PASP or using L-aspartic acid instead of PASP.
The morphology of the products was investigated by a JEOL JSM-6700F field
emission scanning electron microscope (FESEM). Focused ion beam (FIB) analysis
was conducted on the dual beam FIB/SEM system employing a FEI Helios NanoLab
650 microscope, equipped with a gallium ion source operating in an accelerating-
voltage range 0.5–30 kV and an omniprobeTM micromanipulator. X-ray diffraction
patterns (XRD) were recorded on a Japan MapAHF X-ray diffractometer equipped
with Cu Ka irradiation (l 5 0.154056 nm). Infrared spectrum analysis was con-
ducted on aNicolet 8700 FT-IR spectrophotometer onKBr pellets. The products were
further investigated by thermogravimetric and differential thermal analysis (TG-
DTA) employing a SDTQ 600 TG/DTA thermal analyzer with a heating rate of 10uC/
min from room temperature to 1000uC under air gas flow.
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